An information platform for unlisted & pre-IPO sharesNot a SEBI-recognised stock exchange or trading platformAll prices are indicative
UnlistedZone
Home › Knowledge › API Holdings’ ₹347.5 Cr Akna Medical Share Swap Explained
Knowledge27 Oct 2026

API Holdings’ ₹347.5 Cr Akna Medical Share Swap Explained

PharmEasy’s parent API Holdings wants full control of Akna Medical, its medicine wholesale arm. But instead of paying cash, it’s handing Lightrock ₹347.5 crore worth of new shares. We break down the deal, what a CCPS is, why it could point to an IPO, and what it means for shareholders voting by November 15.

This video explains API Holdings’ plan to buy Lightrock’s 31.33% stake in Akna Medical through a ₹347.5 crore share swap instead of cash. It covers what Akna does, how CCPS shares work, why the deal may point to a pre-IPO consolidation, 2.87% dilution, and how shareholders vote by November 15.

Disclaimer: This article is for informational purposes only and is not investment advice, nor an offer to buy or sell any security. Unlisted share prices are indicative. Please do your own research or consult a SEBI-registered advisor before investing.
Share this